EAACI Congress 2024

31 May - 03 June 2024 Valencia, Spain

TPS25 - AllergoOncology

Friday 31 May, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
"For now we see in a mirror, dimly": monocytosis, eosinophilia, basophilia in pancreatic and breast cancer patients
Adverse infusion reaction during Amivantamab administration
C1 inhibitor deficiency: a long road from the diagnosis of possible hereditary angioedema to the diagnosis of splenic marginal zone lymphoma
Cytokine release syndrome due to intravenous trastuzumab with tolerance of subcutaneous administration
Desensitization in a patient with carboplatin anaphylaxis and mastocytosis
Desensitization to Darratumumab and mastocyte cytoreduction in patient with systemic mastocytosis Smouldering and Multiple Myeloma
Development of caninized anti-PD1 and anti-PD-L1 mAbs with canine constant regions IgG1 and IgG4 for cancer therapy
Management decisions in 13 patients with hypersensitivity reactions to chemotherapy agents
Omalizumab to the rescue for severe anaphylaxis in desensitization to carboplatin
Rapid drug desensitization to taxanes: a descriptive study from Turkey
Risk Factors in Breakthrough Reactions during Monoclonal Antibody Desensitization
Successful Rapid Desensitization with Atezolizumab after severe hypersensitivity reation in a patient with small-cell lung metastatic cancer: a case report
Total serum IgE in pancreatic cancer patients: pilot study